With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...

Rancho BioSciences, the premier tech-enabled data science partner for biopharma, headquartered in San Diego, California, is ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...